Clinical Trial Update: Reduced Intensity Conditioning Transplant Using Haploidentical Donors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating reduced intensity conditioning transplant using haploidentical donors for various hematologic malignancies; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Cmml
• Hodgkin Lymphoma
• Lymphocytic Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Myelofibrosis
• Myelogenous Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Haploidentical donor hematopoietic cell transplant

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-04-27